Cardiac Marker Testing Market By Type (Troponin I and T, CK-MB, BNP Or NT-PROBNP,), Disease, Type of Testing (Laboratory Testing, Point-Of-Care Testing) and Region, Global trends and forecast from 2022 to 2029

Published on: May 2022
From:USD $3499.00
Number Of Pages:133

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 7.75 billion	8.9%	North America

By Type	By Product	By Type of Testing
Troponin I and T CK-MB BNP Or NT-PROBNP Myoglobin HSCRP Other Biomarkers	Instruments Chemiluminescence Immunofluorescence ELISA Immunochromatography Reagents and Kits	Laboratory Testing Point-Of-Care Testing

4.6/5 - (39 votes)

Cardiac Marker Testing Market Overview

The global cardiac marker testing market is expected to grow at 8.9% CAGR from 2022 to 2029. It is expected to reach above USD 7.75 billion by 2029 from USD 3.6 billion in 2020.

Cardiac markers are used in the treatment and risk stratification of patients with the suspected coronary acute syndrome (ACS). Troponin I and T, HDCRP, myoglobin, CK-MB, and other cardiac marker tests are among the most common. When the heart is stressed or injured, substances called cardiac markers are released into the blood. Hormones, enzymes, and proteins are examples of these markers. These biomarkers can be used to detect a variety of heart disorders, including acute coronary syndrome, cardiac ischemia, and conditions involving obstructed blood flow to the heart. Physicians perform several cardiac marker tests over several hours to keep track of the blood sugar increase and determine the severity of a heart attack. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. It is ideally suited to both point of care testing and laboratory use. Cardiac biomarkers are protein molecules that are released into the blood after heart damage or heart-stress. These biomarkers act as a potential tool to detect various cardiovascular diseases (CVD) including cardiac ischemia, myocardial infarction, congestive heart failure, and acute coronary syndrome (ACS). Cardiac biomarker tests allow the doctor to determine the risk of a patient associated with such diseases.

ATTRIBUTE	DETAILS
Study period	2020-2029
Base year	2021
Estimated year	2022
Forecasted year	2022-2029
Historical period	2018-2020
Unit	Value (USD Billion)
Segmentation	By Type, By Product, By Disease, By Type of Testing, By Region
By Type	Troponin I and T CK-MB BNP Or NT-PROBNP Myoglobin HSCRP Other Biomarkers
By Product	Instruments Chemiluminescence Immunofluorescence ELISA Immunochromatography Reagents and Kits
By Disease	Myocardial Infarction Congestive Heart Failure
By Type of Testing	Laboratory Testing Point-Of-Care Testing
By Region	North America Europe Asia Pacific South America Middle East and Africa

The growth in increasing prevalence of cardiovascular diseases along with rising hear diseases across the globe is the significant factor responsible for driving the growth of the cardiac marker testing market in the above-mentioned forecast period. Additionally, the factors such as rising aging population, increasing clinical trials for the identification of cardiac biomarkers and growing funding from public–private organizations for research on cardiac biomarkers also heighten the overall growth of the market. The growing funding from public and private organizations for research on cardiac biomarkers are also estimated to accelerate the overall growth of the market. However, the high cost of testing obstructs the market’s growth. The increasing problems associated with the sample collection and storage are also estimated to be the restraint that will hamper the overall growth of the market.

The ongoing clinical trials for the identification of novel cardiac biomarkers and technological advancement are expected to generate profitable opportunities for the market. On the other hand, the complexity associated with the reimbursement system have the potential to challenge for the market’s growth.

The POC cardiac marker market is a fast-growing segment of the overall global IVD industry. The increasing adoption of sensitivity and premium-priced POC Troponin tests is contributing to the growth of the global market. The growing move towards value-based and efficient healthcare service delivery against the backdrop of stringent budgets is boosting the prospects for POC Cardiac testing market. Moreover, the majority of medical professionals opt of POC cardiac testing to quickly monitor the condition of patients experiencing chest pain or other heart ailment symptoms in emergency care environments. The global phenomenon of the burgeoning aging populace is driving demand for POC test kits for use in home healthcare and old age homes. Growing patient awareness and the increasing availability of over-the-counter POC tests is a major factor propelling the POC tests market.

Cardiac Marker Testing Market | Exactitude Consultancy

Cardiac Marker Testing Market Segment Analysis

The global Cardiac marker testing market is segmented based on type, disease, product, type of testing and region. Based on type, the cardiac marker testing market is segmented into Troponin I and T, CK-MB, BNP Or NT-PROBNP, myoglobin, HSCRP, other biomarkers. The troponin segment held the largest share in 2020 and is anticipated to maintain its dominance during the forecast period. This large share is due to increase in the prevalence of acute coronary syndrome and myocardium infarction, rise in the number of congestive heart failure cases across the globe are the key factors to drive the market growth. The creatine kinase is estimated to grow at the highest CAGR 13.0% during the forecast period.

Based on disease, the cardiac marker testing market is segmented into Myocardial Infarction, Congestive Heart Failure. Myocardial infarction is one of the fastest-growing segments, credited to its increase in the rate of sedentary lifestyle among individuals, alcohol consumption, smoking, and unhealthy food habits, resulting in obesity.

Based on the product, the Cardiac marker testing market is segmented into Instruments, Chemiluminescence, Immunofluorescence, ELISA, Immunochromatography, Reagents and Kits.

Based on type of testing, the cardiac marker testing market is segmented into laboratory testing, point-of-care testing. The laboratory testing segment held the largest share in 2020 and is anticipated to maintain its dominance during the forecast period, owing to the reform in healthcare infrastructure, increase in healthcare spending, rise in disposable incomes, and government initiatives for preventing heart attack are expected to drive the cardiac biomarkers testing market in the Asia-Pacific region. Thus, the increase in cardiovascular diseases (CVDs) around the globe, has augmented the demand for cardiac biomarkers testing for lowering the burden of heart attack and other CVDs.

Cardiac Marker Testing Market Players

The cardiac marker testing market key players include Abbott Laboratories, Becton, Dickinson and Company, bioMerieux, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Siemens AG, Thermo Fisher Scientific, Inc., and Tosoh Corporation.

To increase their market position, these businesses have implemented a variety of growth tactics. These companies are using expansion, new product development, mergers and acquisitions, and collaboration as important growth strategies to improve their product portfolio and geographical presence in order to meet the rising demand for cardiac marker testing from emerging economies.

Who Should Buy? Or Key Stakeholders

Healthcare industries.
Life Sciences
Institutional & retail players.
Investment research firms
Others

Cardiac Marker Testing Market Regional Analysis

The cardiac marker testing market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

The North American market is predicted to hold the largest share of the global cardiac marker testing market, followed by Europe during the forecast period, because of the prevalence of cardiovascular disorders, the public and private investments, NIH funding for creating novel cardiac biomarkers, and the growing geriatric population, North America is expected to be the largest market. furthermore, government and research institute measures to fight critical cardiac diseases and an increase in R&D activities related to cardiac biomarkers, driving market growth in North America.

Key Market Segments: Cardiac Marker Testing Market

Cardiac Marker Testing Market by Type, 2020-2029, (USD Million), (Thousand Units)

Troponin I And T
CK-Mb
BNP OR NT-PROBNP
Myoglobin
HSCRP
Other Biomarkers

Cardiac Marker Testing Market by Disease, 2020-2029, (USD Million), (Thousand Units)

Myocardial Infarction
Congestive Heart Failure

Cardiac Marker Testing Market by Product, 2020-2029, (USD Million), (Thousand Units)

Instruments
Chemiluminescence
Immunofluorescence
Elisa
Immunochromatography
Reagents And Kits

Cardiac Marker Testing Market by Type of Testing, 2020-2029, (USD Million), (Thousand Units)

Laboratory Testing
Point-Of-Care Testing

Cardiac Marker Testing Market by Region, 2020-2029, (USD Million), (Thousand Units)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries In All Regions Are Covered.

Key Question Answered

What is the current size of the cardiac marker testing market?
What are the key factors influencing the growth of cardiac marker testing?
What are the major applications for cardiac marker testing?
Who are the major key players in the cardiac marker testing market?
Which region will provide more business opportunities for cardiac marker testing in future?
Which segment holds the maximum share of the cardiac marker testing market?

Introduction
1. Market Definition
2. Market Segmentation
3. Research Timelines
4. Assumptions and Limitations
Research Methodology
1. Data Mining
  1. Secondary Research
  2. Primary Research
  3. Subject-Matter Experts’ Advice
2. Quality Checks
  1. Final Review
3. Data Triangulation
  1. Bottom-Up Approach
  2. Top-Down Approach
  3. Research Flow
4. Data Sources
Executive Summary
Market Overview
1. Global Cardiac Marker Testing Market Outlook
  1. Market Drivers
  2. Market Restraints
  3. Market Opportunities
2. Impact of Covid-19 On Cardiac Marker Testing Market
3. Porter’s five forces model
  1. Threat from new entrants
  2. Threat from substitutes
  3. Bargaining power of suppliers
  4. Bargaining power of customers
  5. Degree of competition
4. Industry value chain Analysis
Global Cardiac Marker Testing Market by Type
1. Extruded Sheet
2. Cast Acrylic Sheet
3. Beads And Pellets
Global Cardiac Marker Testing Market by Product
1. Instruments
2. Chemiluminescence
3. Immunofluorescence
4. ELISA
5. Immunochromatography
6. Reagents and Kits
Global Cardiac Marker Testing Market by Disease
1. Myocardial Infarction
2. Congestive Heart Failure
Global Cardiac Marker Testing Market by Type of Testing
1. Laboratory Testing
2. Point-Of-Care Testing
Global Cardiac Marker Testing Market by Region
1. North America
  1. US
  2. Canada
  3. Mexico
2. South America
  1. Brazil
  2. Argentina
  3. Colombia
  4. Chile
  5. Rest Of South America
3. Europe
  1. Germany
  2. UK
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Netherlands
  8. Belgium
  9. Rest Of Europe
4. Asia Pacific
  1. India
  2. China
  3. Japan
  4. South Korea
  5. Australia
  6. New Zealand
  7. Indonesia
  8. Taiwan
  9. Malaysia
  10. Rest Of Asia Pacific
5. Middle East and Africa
  1. UAE
  2. Saudi Arabia
  3. South Africa
  4. Rest Of Middle East and Africa

Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)

Abbott Laboratories
Becton
Dickinson and Company
bioMerieux, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Hoffmann-La Roche Ltd.
PerkinElmer Inc.
Siemens AG
Thermo Fisher Scientific, Inc.
Tosoh Corporation *The Company List Is Indicative

LIST OF TABLES

TABLE 1 GLOBAL CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 2 GLOBAL CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 3 GLOBAL CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 4 GLOBAL CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 5 GLOBAL CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 6 GLOBAL CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 7 GLOBAL CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 8 GLOBAL CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 9 GLOBAL CARDIAC MARKER TESTING MARKET BY REGION (USD MILLIONS), 2020-2029

TABLE 10 GLOBAL CARDIAC MARKER TESTING MARKET BY REGION (THOUSAND UNITS), 2020-2029

TABLE 11 NORTH AMERICA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 12 NORTH AMERICA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 13 NORTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 14 NORTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 15 NORTH AMERICA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 16 NORTH AMERICA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 17 NORTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 18 NORTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 19 US CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 20 US CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 21 US CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 22 US CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 23 US CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 24 US CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 25 US CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 26 US CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 27 CANADA CARDIAC MARKER TESTING MARKET BY PRODUCT (MILLIONS), 2020-2029

TABLE 28 CANADA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 29 CANADA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 30 CANADA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 31 CANADA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 32 CANADA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 33 CANADA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 34 CANADA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 35 MEXICO CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 36 MEXICO CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 37 MEXICO CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 38 MEXICO CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 39 MEXICO CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 40 MEXICO CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 41 MEXICO CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 42 MEXICO CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 43 SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 44 SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 45 SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 46 SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 47 SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 48 SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 49 SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 50 SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 51 BRAZIL CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 52 BRAZIL CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 53 BRAZIL CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 54 BRAZIL CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 55 BRAZIL CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 56 BRAZIL CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 57 BRAZIL CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 58 BRAZIL CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 59 ARGENTINA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 60 ARGENTINA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 61 ARGENTINA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 62 ARGENTINA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 63 ARGENTINA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 64 ARGENTINA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 65 ARGENTINA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 66 ARGENTINA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 67 COLOMBIA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 68 COLOMBIA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 69 COLOMBIA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 70 COLOMBIA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 71 COLOMBIA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 72 COLOMBIA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 73 COLOMBIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 74 COLOMBIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 75 REST OF SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 76 REST OF SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 77 REST OF SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 78 REST OF SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 79 REST OF SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 80 REST OF SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 81 REST OF SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 82 REST OF SOUTH AMERICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 83 ASIA-PACIFIC CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 84 ASIA-PACIFIC CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 85 ASIA-PACIFIC CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 86 ASIA-PACIFIC CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 87 ASIA-PACIFIC CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 88 ASIA-PACIFIC CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 89 ASIA-PACIFIC CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 90 ASIA-PACIFIC CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 91 INDIA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 92 INDIA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 93 INDIA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 94 INDIA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 95 INDIA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 96 INDIA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 97 INDIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 98 INDIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 99 CHINA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 100 CHINA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 101 CHINA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 102 CHINA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 103 CHINA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 104 CHINA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 105 CHINA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 106 CHINA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 107 JAPAN CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 108 JAPAN CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 109 JAPAN CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 110 JAPAN CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 111 JAPAN CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 112 JAPAN CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 113 JAPAN CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 114 JAPAN CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 115 SOUTH KOREA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 116 SOUTH KOREA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 117 SOUTH KOREA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 118 SOUTH KOREA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 119 SOUTH KOREA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 120 SOUTH KOREA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 121 SOUTH KOREA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 122 SOUTH KOREA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 123 AUSTRALIA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 124 AUSTRALIA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 125 AUSTRALIA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 126 AUSTRALIA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 127 AUSTRALIA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 128 AUSTRALIA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 129 AUSTRALIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 130 AUSTRALIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 131 SOUTH EAST ASIA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 132 SOUTH EAST ASIA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 133 SOUTH EAST ASIA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 134 SOUTH EAST ASIA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 135 SOUTH EAST ASIA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 136 SOUTH EAST ASIA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 137 SOUTH EAST ASIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 138 SOUTH EAST ASIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 139 REST OF ASIA PACIFIC CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 140 REST OF ASIA PACIFIC CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 141 REST OF ASIA PACIFIC CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 142 REST OF ASIA PACIFIC CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 143 REST OF ASIA PACIFIC CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 144 REST OF ASIA PACIFIC CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 145 REST OF ASIA PACIFIC CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 146 REST OF ASIA PACIFIC CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 147 EUROPE CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 148 EUROPE CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 149 EUROPE CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 150 EUROPE CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 151 EUROPE CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 152 EUROPE CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 153 EUROPE CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 154 EUROPE CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 155 GERMANY CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 156 GERMANY CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 157 GERMANY CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 158 GERMANY CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 159 GERMANY CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 160 GERMANY CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 161 GERMANY CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 162 GERMANY CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 163 UK CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 164 UK CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 165 UK CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 166 UK CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 167 UK CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 168 UK CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 169 UK CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 170 UK CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 171 FRANCE CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 172 FRANCE CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 173 FRANCE CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 174 FRANCE CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 175 FRANCE CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 176 FRANCE CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 177 FRANCE CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 178 FRANCE CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 179 ITALY CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 180 ITALY CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 181 ITALY CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 182 ITALY CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 183 ITALY CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 184 ITALY CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 185 ITALY CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 186 ITALY CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 187 SPAIN CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 188 SPAIN CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 189 SPAIN CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 190 SPAIN CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 191 SPAIN CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 192 SPAIN CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 193 SPAIN CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 194 SPAIN CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 195 RUSSIA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 196 RUSSIA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 197 RUSSIA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 198 RUSSIA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 199 RUSSIA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 200 RUSSIA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 201 RUSSIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 202 RUSSIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 203 REST OF EUROPE CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 204 REST OF EUROPE CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 205 REST OF EUROPE CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 206 REST OF EUROPE CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 207 REST OF EUROPE CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 208 REST OF EUROPE CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 209 REST OF EUROPE CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 210 REST OF EUROPE CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 211 MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 212 MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 213 MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 214 MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 215 MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 216 MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 217 MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 218 MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 219 UAE CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 220 UAE CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 221 UAE CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 222 UAE CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 223 UAE CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 224 UAE CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 225 UAE CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 226 UAE CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 227 SAUDI ARABIA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 228 SAUDI ARABIA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 229 SAUDI ARABIA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 230 SAUDI ARABIA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 231 SAUDI ARABIA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 232 SAUDI ARABIA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 233 SAUDI ARABIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 234 SAUDI ARABIA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 235 SOUTH AFRICA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 236 SOUTH AFRICA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 237 SOUTH AFRICA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 238 SOUTH AFRICA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 239 SOUTH AFRICA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 240 SOUTH AFRICA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 241 SOUTH AFRICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 242 SOUTH AFRICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

TABLE 243 REST OF MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 244 REST OF MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 245 REST OF MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 246 REST OF MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 247 REST OF MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY DISEASE (USD MILLIONS), 2020-2029

TABLE 248 REST OF MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY DISEASE (THOUSAND UNITS), 2020-2029

TABLE 249 REST OF MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (USD MILLIONS), 2020-2029

TABLE 250 REST OF MIDDLE EAST AND AFRICA CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL CARDIAC MARKER TESTING MARKET BY TYPE, USD MILLION, 2020-2029

FIGURE 9 GLOBAL CARDIAC MARKER TESTING MARKET BY PRODUCT, USD MILLION, 2020-2029

FIGURE 10 GLOBAL CARDIAC MARKER TESTING MARKET BY DISEASE, USD MILLION, 2020-2029

FIGURE 11 GLOBAL CARDIAC MARKER TESTING MARKET BY TYPE OF TESTING, USD MILLION, 2020-2029

FIGURE 12 GLOBAL CARDIAC MARKER TESTING MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 13 PORTER’S FIVE FORCES MODEL

FIGURE 14 MARKET SHARE ANALYSIS

FIGURE 15 ABBOTT LABORATORIES: COMPANY SNAPSHOT

FIGURE 16 BECTON: COMPANY SNAPSHOT

FIGURE 17 DICKINSON AND COMPANY: COMPANY SNAPSHOT

FIGURE 18 BIOMERIEUX, INC.: COMPANY SNAPSHOT

FIGURE 19 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT

FIGURE 20 DANAHER CORPORATION: COMPANY SNAPSHOT

FIGURE 21 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT

FIGURE 22 PERKINELMER INC.: COMPANY SNAPSHOT

FIGURE 23 SIEMENS AG: COMPANY SNAPSHOT

FIGURE 24 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT

FIGURE 25 TOSOH CORPORATION: COMPANY SNAPSHOT

• What is the worth of global cardiac marker testing market?

The cardiac marker testing market size had crossed USD 3.6 billion in 2020 and will observe a CAGR of more than 8.9% up to 2029 driven by the growth in increasing prevalence of cardiovascular diseases along with rising hear diseases across the globe.

• What is the size of the North America cardiac marker testing industry?

North America held more than 35% of the cardiac marker testing market revenue share in 2020 due to the prevalence of cardiovascular disorders, the public and private investments, NIH funding for creating novel cardiac biomarkers, and the growing geriatric population.

• What are the upcoming trends of cardiac marker testing market, globally?

The upcoming trends in cardiac marker testing market are the ongoing clinical trials for the identification of novel cardiac biomarkers and technological advancement.

• What is the CAGR of cardiac marker testing market?

The global cardiac marker testing market registered a CAGR of 8.9% from 2022 to 2029. The troponin segment was the highest revenue contributor to the market, with 1 billion in 2020, and is estimated to reach 1.69 billion by 2029, with a CAGR of 6%.

• Which are the top companies to hold the market share in cardiac marker testing market?

• What is the leading application of cardiac marker testing market?

Leading application of cardiac marker testing market is laboratory testing. The laboratory testing segment held the largest share in 2020 and is anticipated to maintain its dominance during the forecast period, owing to the reform in healthcare infrastructure, increase in healthcare spending, rise in disposable incomes, and government initiatives for preventing heart attack.

• Which is the largest regional market for cardiac marker testing market?

North America is expected to hold the largest market share in terms of revenue, during the forecast period. The growth is attributed to prevalence of cardiovascular disorders, the public and private investments, NIH funding for creating novel cardiac biomarkers, and the growing geriatric population.

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT

Cardiac Marker Testing Market Overview

Cardiac Marker Testing Market Segment Analysis

Cardiac Marker Testing Market Players

Who Should Buy? Or Key Stakeholders

Cardiac Marker Testing Market Regional Analysis

Key Market Segments: Cardiac Marker Testing Market

Key Question Answered

Table of Content

LIST OF TABLES

LIST OF FIGURES

FAQ

DOWNLOAD FREE SAMPLE REPORT

Inquire for Discount

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

6 Elmore Road, Luton, Bedfordshire LU20QB, UK

Plot No. 39, SR, 10-16, NDA Pashan Rd, Bavdhan, Pune, Maharashtra 411021

Subscribe our newsletter

Cardiac Marker Testing Market By Type (Troponin I and T, CK-MB, BNP Or NT-PROBNP,), Disease, Type of Testing (Laboratory Testing, Point-Of-Care Testing) and Region, Global trends and forecast from 2022 to 2029

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT

Cardiac Marker Testing Market Overview

Cardiac Marker Testing Market Segment Analysis

Cardiac Marker Testing Market Players

Who Should Buy? Or Key Stakeholders

Cardiac Marker Testing Market Regional Analysis

Key Market Segments: Cardiac Marker Testing Market

Key Question Answered

Table of Content

LIST OF TABLES

LIST OF FIGURES

FAQ

Related Reports

DOWNLOAD FREE SAMPLE REPORT

Inquire for Discount

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure